Citation:Roteli-Martins CM, Naud P, De Borba P, Teixeira JC, De Carvalho NS, Zahaf T, et al 2012
From National Cancer Control Policy
Roteli-Martins CM, Naud P, De Borba P, Teixeira JC, De Carvalho NS, Zahaf T, et al. Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up. Hum Vaccin Immunother 2012 Mar;8(3):390-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22327492.
Critical appraisals